Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Axial Spondyloarthritis Not Fulfilling Modified New York Criteria
2009-010643-14Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- May 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in axial spondyloarthritis (axSpA), spondyloarthritis (SpA), sponsored by Abbott Laboratories. Started May 2009; status: completed.
02
Drugs
03
Conditions
axial spondyloarthritis (axSpA)spondyloarthritis (SpA)
Beyond the preview
Go deeper on 2009-010643-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010643-14.